Markers of anti-malarial drug resistance in Plasmodium falciparum isolates from Swaziland: Identification of pfmdr1-86F in natural parasite isolates

Malaria Journal

Volumn 9, Issue 1, 2010, Pages

  Dlamini, Sabelo V ^a,b   Beshir, Khalid ^b   Sutherland, Colin J ^b  

^a UNIVERSITY OF SWAZILAND   (Swaziland)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; ASPARAGINE; CHLOROQUINE; FANSIDAR; PHENYLALANINE; ANTIMALARIAL AGENT; MDR1 PROTEIN, PLASMODIUM FALCIPARUM; MULTIDRUG RESISTANCE PROTEIN; PYRIMETHAMINE; SULFADOXINE; SULFADOXINE-PYRIMETHAMINE;

AMINO ACID SUBSTITUTION; ANTIMALARIAL DRUG RESISTANCE; GENE; GENE AMPLIFICATION; HUMAN; NONHUMAN; PARASITE ISOLATION; PARASITE SURVIVAL; PFCRT GENE; PFDHFR GENE; PFDHPS GENE; PFMDR1 GENE; PLASMODIUM FALCIPARUM; REVIEW; SWAZILAND; ALLELE; AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; ANIMAL; ARTICLE; DNA SEQUENCE; DRUG COMBINATION; DRUG EFFECT; DRUG RESISTANCE; GENETICS; GENOTYPE; ISOLATION AND PURIFICATION; MALARIA FALCIPARUM; PARASITOLOGY; RETROSPECTIVE STUDY;

ALLELES; AMPLIFIED FRAGMENT LENGTH POLYMORPHISM ANALYSIS; ANIMALS; ANTIMALARIALS; CHLOROQUINE; DRUG COMBINATIONS; DRUG RESISTANCE; GENOTYPE; HUMANS; MALARIA, FALCIPARUM; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PLASMODIUM FALCIPARUM; PYRIMETHAMINE; RETROSPECTIVE STUDIES; SEQUENCE ANALYSIS, DNA; SULFADOXINE; SWAZILAND;

EID: 77950293606     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-9-68     Document Type: Review

References (42)

1. Appearance of chloroquine-resistant falciparum malaria in Swaziland. MC Raviglione, Lancet 1987 2 44 45 10.1016/S0140-6736(87)93080-7 2885531
2. Antimalarial drug resistance. NJ White, J Clin Invest 2004 113 1084 1092 15085184
3. Existencia in Mozambique de malaria P. falciparum resistance a chloroquine (1983-1984). ALT Franco J Schwalback A Fernandes A Schapira, Revista Medica de Mozambique 1984 2 83 85
4. A malaria resistante em Mocambique. Epidemiology e control 1983-1987. Instituto Nacionale de Saude, Maputo. In: Abacassamo et al. 2004. Efficacy of chloroquine, amodiaquine, sulphadoxine-pyrimethamine and combination therapy with artesunate in Mozambican children with non-complicated malaria [Abstract]. A Schapira JFL Schwalback, Trop Med Int Health 1989 9 200 208
5. Evaluation of four therapeutic regimens for falciparum malaria in Mozambique, 1986. A Schapira J Schwalback, Bull World Health Organ 1988 66 219 226 3293827
6. In vitro confirmation of chloroquine-resistant Plasmodium falciparum malaria in KwaZulu. JA Freese BL Sharp SM Ngxongo MB Markus, S Afr Med J 1988 74 576 578 3057656
7. Mutations in the P. falciparum digestive vacuole trans-membrane protein pfcrt and evidence for their role in chloroquine resistance. DA Fidock T Nomura AK Talley RA Cooper SM Dzekunov MT Ferdig LM Ursos AB Sidhu B Naude KW Deitsch XZ Su JC Wootten PD Roepe TE Wellems, Mol Cell 2000 6 861 871 10.1016/S1097-2765(05)00077-8 11090624
8. A requiem for chloroquine. IM Hastings PG Bray SA Ward, Science 2002 298 74 75 10.1126/science.1077573 12364772
9. Several alleles of the multi drug-resistance gene are closely linked to chloroquine resistant Plasmodium falciparum. S Foote D Kyle R Martin A Oduola K Forsyth D Kemp A Cowman, Nature 1990 345 255 258 10.1038/345255a0 2185424
10. The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the antimalarials mefloquine and artemisinin. MT Duraisingh P Jones I Sambou L von Seidlein M Pinder DC Warhurst, Mol Biochem Parasitol 2000 108 13 23 10.1016/S0166-6851(00)00201-2 10802315
11. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. MB Reed KJ Saliba SR Caruana K Kirk AF Cowman, Nature 2000 403 906 909 10.1038/35002615 10706290
12. In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem). C Sisowath J Stromberg A Martensson M Msellem C Obondo A Bjorkman JP Gil, J Infect Dis 2005 191 1014 1017 10.1086/427997 15717281
13. Amodiaquine and Artemether-Lumefantrine Select Distinct Alleles of Plasmodium falciparum mdr1 Gene in Tanzanian Children Treated for Uncomplicated malaria. GS Humphreys I Merinopoulos J Ahmed CJM Whitty TK Mutabingwa CJ Sutherland R Hallett, Antimicrob Agents Chemother 2007 51 991 997 10.1128/AAC.00875-06 17194834
14. Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multi-drug resistant Plasmodium falciparum malaria. RN Price AC Uhleman M van Vugt A Brockman R Hatagalung S Nair D Nash P Singhasivanon TJC Anderson S Krishna NJ White F Nosten, Clin Infect Dis 2006 42 1570 1577 10.1086/503423 16652314
15. Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. DS Peterson D Walliker TE Wellems, Proc Natl Acad Sci USA 1988 85 9114 9118 10.1073/pnas.85.23.9114 2904149
16. Mutations in dyhydropteroate synthase are responsible for sulfone and sulphonamide resistance in Plasmodium falciparum. T Triglia JG Menting C Wilson AF Cowman, Proc Natl Acad Sci USA 1997 94 13944 13949 10.1073/pnas.94.25.13944 9391132
17. Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum. A Cowman MJ Morry BA Biggs GAM Cross SJ Foote, Proc Natl Acad Sci USA 1988 85 9109 9113 10.1073/pnas.85.23.9109 3057499
18. The dihydrofolate reductase-thymidylate synthetase gene in the drug resistance of malaria parasites. JE Hyde, Pharmacol Ther 1990 48 45 49 10.1016/0163-7258(90)90017-V 2274577
19. Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase: dihydropteroate synthase gene lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine. R Brooks P Wang M Read MW Watkins PFG Sims JE Hyde, J Biochem 1994 224 397 405
20. Primary structure and expression of the dihydropteroate synthetase gene of Plasmodium falciparum. T Triglia A Cowman, Proc Natl Acad Sci USA 1994 91 7149 7153 10.1073/pnas.91.15.7149 8041761
21. Mutations in Plasmodium falciparum dihydrofolate reductase and dyhydopteroate synthetase and epidemiologic patterns of sulfadoxine- pyrimethamine use and resistance. CV Plowe JF Cortese A Djimdé OC Nwanyanwu WM Watkins PA Winstanley JG Estrada-Franco RE Mollinedo JC Avila JL Cespedes D Carter OK Doumbo, J Infect Dis 1997 176 1590 1596 10.1086/514159 9395372
22. Molecular assays for surveillance of antifolate resistant malaria. JG Kublin RS Witzig AH Shankar JQ Zurita RH Gilman JA Guarda JF Cortese CV Plowe, Lancet 1998 351 1629 1630 10.1016/S0140-6736(98)24022-0 9620719
23. Novel pfdhps haplotypes among imported cases of Plasmodium falciparum malaria in the UK. CJ Sutherland H Fifer RJ Pearce F bin Reza M Nicholas T Haustein NE Njimgye-Tekumafor JF Doherty P Gothard SD Polley PL Chiodini, Antimicrob Agents Chemother 2009 53 3405 3410 10.1128/AAC.00024-09 19433569
24. Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. CV Plowe A Djimdé M Bouare O Doumbo TE Wellems, Am J Trop Med Hyg 1995 52 565 568 7611566
25. Chloroquine-resistant Plasmodium falciparum infections among UK travellers returning with malaria after chloroquine prophylaxis. CJ Sutherland T Haustein N Gadalla M Armstrong JF Doherty PL Chiodini, J Antimicr Chemother 2007 59 1197 1199 10.1093/jac/dkm104
26. Molecular determination of point mutation haplotypes in the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum in three districts of Northern Tanzania. RJ Pearce C Drakeley D Chandramohan F Mosha CL Roper, Antimicrob Agents Chemother 2003 47 1347 1354 10.1128/AAC.47.4.1347-1354. 2003 12654669
27. Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdrl gene and cross-resistance to halofantrine and quinine. AF Cowman D Galatis JK Thompson, Proc Natl Acad Sci USA 1994 91 1143 1147 10.1073/pnas.91.3.1143 8302844
28. Mutations associated with sulfadoxine-pyrimethamine and chlorproguanil resistance in Plasmodium falciparum isolates from Blantyre, Malawi. AP Alker V Mwapasa A Purfield SJ Rogerson ME Molyneux DD Kamwendo E Tadesse E Chaluluka SR Meshnick, Antimicrob Agents Chemother 2005 49 3919 3921 10.1128/AAC.49.9.3919- 3921.2005 16127071
29. Seven years of regional malaria control collaboration-Mozambique, South Africa and Swaziland. BL Sharp I Kleinschimidt E Streat R Maharaj KI Barnes DN Durrheim FR Ridl N Morris I Seocharan S Kunene JJP LaGrange JD Mthembu F Martens CL Martin A Barreto, Am J Trop Med Hyg 2007 76 42 47 17255227
30. A molecular marker for chloroquine resistant falciparum malaria. A Djimdé OK Doumbo JF Cortese K Kayentao S Doumbo Y Diourté A Dicko X Su T Nomura DA Fidock TE Wellems CV Plowe, N Engl J Med 2001 344 257 263 10.1056/NEJM200101253440403 11172152
31. Genetic diversity and chloroquine selective sweeps in Plasmodium falcip arum. JC Wootton X Feng MT Ferdig RA Cooper J Mu DI Baruch AJ Magill XZ Su, Nature 2002 418 320 323 10.1038/nature00813 12124623
32. Occurrence of the South Asian/South American SVMNT haplotype of the chloroquine-resistance transporter gene in Plasmodium falciparum in Tanzania. M Alifrangis MB Dalgaard JP Lusingu LS Vestergaard T Staalsoe AT Jensen A Enevold AM Ronn IF Khalil DC Warhurst MM Lemnge TG Theander IC Bygbjerg, J Infect Dis 2006 193 1738 1741 10.1086/504269 16703518
33. The pfcrt (K76T) point mutation favours clone multiplicity and disease severity in Plasmodium falciparum infection. MR Ranjit A Das GP Chhotray BN Das AS Acharya, Trop Med Int Health 2004 9 857 861 10.1111/j.1365-3156.2004.01286.x 15303989
34. Carriage of chloroquine-resistant parasites and delay of effective treatment increase the risk of severe malaria in Gambian children. L Meerman R Ord J Teun Bousema M van Niekerk E Osman R Hallett M Pinder G Walraven CJ Sutherland, J Infect Dis 2005 192 1651 1657 10.1086/496887 16206082
35. Combination therapy counteracts the enhanced transmission of drug resistant malaria parasites to mosquito. RL Hallett CJ Sutherland N Alexander R Ord M Jawara CJ Drakeley M Pinder G Walraven GAT Targett A Alloueche, Antimicrob Agents Chemother 2004 48 3940 3943 10.1128/AAC.48.10.3940-3943.2004 15388456
36. Chloroquine/sulphadoxine-pyrimethamine for gambian children with malaria: transmission to mosquitoes of multidrug-resistant Plasmodium falciparum. RL Hallett S Dunyo R Ord M Jawara M Pinder A Randall A Alloueche G Walraven GAT Targett N Alexander CJ Sutherland, PLoS Clin Trials 2006 1 15 DOI; 10.1371/journal.pctr.0010015 10.1371/journal.pctr.0010015 16871318
37. Gambian children successfully treated with chloroquine can harbour and transmit Plasmodium falciparum gametocytes carrying resistant genes. CJ Sutherland A Alloueche J Curtis CJ Drakeley R Ord M Duraisingh B Greenwood M Pinder D Warhurst GAT Targett, Am J Trop Med Hyg 2002 67 578 585 12518847
38. Pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum. AB Sidhu SG Valderramos DA Fidock, Mol Microbiol 2005 57 913 926 10.1111/j.1365-2958.2005.04729.x 16091034
39. Differential effect of regional drug pressure on dihydrofolate reductase and dihydrofolate synthetase mutations in southern Mozambique. J Raman B Sharp I Kleinschimidt C Roper E Streat V Kelly KI Barnes, Am J Trop Med Hyg 2008 78 256 261 18256426
40. Antifolate antimalarial resistance in southeast Africa: a population-based analysis. C Roper R Pearce B Bredenkemp J Gumede C Drakeley F Mosha D Chandramohan B Sharp, Lancet 2003 361 1174 1181 10.1016/S0140-6736(03) 12951-0 12686039
41. Selection of pfmdr1 mutations after amodiaquine monotherapy and amodiaquine plus artemisinin combination therapy in East Africa. G Holmgren J Hamrin J Svärd A Mårtensson J Pedro Gil A Björkman, Infect Gen Evol 2007 7 562 569 10.1016/j.meegid.2007.03.005
42. Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations. AB Sidhu D Verdier-Pinard DA Fidock, Science 2002 298 210 213 10.1126/science.1074045 12364805